Derangement of Liver Enzymes, Hyperglycemia, Anemia, and Associated Factors among HIV-Infected Patients Treated with Tenofovir Disoproxil Fumarate-Based Regimen in Ethiopia: A Prospective Cohort Study
Table 1
Characteristics of study participants.
Variable
Category
Frequency
Age in years
>40
21 (33.3)
Body mass index (in kg/m2)
≥25
20 (31.75)
Baseline CD4 count
≥200 cells/mm3
34 (53.97)
WHO stage
I + II
45 (71.43)
III + IV
18 (28.57)
Marital status
Single
8 (12.7)
Married
40 (63.5)
Divorced
11 (17.5)
Widowed
4 (6.4)
Educational status
Illiterate
5 (7.9)
Primary
18 (28.6)
Secondary
28 (44.4)
Diploma
5 (7.9)
Degree
7 (11.1)
Occupation
Governmental employee
12 (19)
Private
34 (54)
Not employed
17 (27)
Cotrimoxazole px
Yes
42 (66.7)
Isoniazid px
Yes
8 (12.7)
Chemotherapy
Yes
4 (6.3)
NSAIDs
Yes
6 (9.5)
PPI
Yes
9 (14.3)
Antituberculosis drugs
Yes
4 (6.3)
Cancer
Yes
8 (12.7)
CD4: cluster of differentiation; WHO: World Health Organization; Px: prophylaxis; NSAIDs: nonsteroidal anti-inflammatory drugs; PPI: proton pump inhibitor.